Sertoli cell (SC) and sertoliform tumors of the testis are very uncommon; for this reason their
differential diagnosis and classification can be challenging. We applied an extensive
immunophenotypic panel that included androgenic hormones, enzymes and receptors,
neuroendocrine, lineage and genitourinary markers to a series of these lesions to determine
if and which immunostains can aid in their diagnostic workup. Study cases included: 2
androgen insensitivity syndrome–associated SC adenomas, 3 SC tumors (SCT) not …